Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Zhao, Yu  [Clear All Filters]
2023
Yan S, Zheng X, Lin Y, Li C, Liu Z, Li J, Tu Z, Zhao Y, Huang C, Chen Y, et al. Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington's disease. Nat Biomed Eng. 2023.
Liu Q, Zhao Y, Wang Q, Yan L, Fu X, Xiao R. Convergent alteration of the mesenchymal stem cell heterogeneity in adipose tissue during aging. FASEB J. 2023;37(8):e23114.
Jin Q, Liu X, Zhuang Z, Huang J, Gou S, Shi H, Zhao Y, Ouyang Z, Liu Z, Li L, et al. Doxycycline-dependent Cas9-expressing pig resources for conditional in vivo gene nullification and activation. Genome Biol. 2023;24(1):8.
Jia J, Zhao Y, Wang J-H, Kuang Y-Q. Isolating peripheral blood mononuclear cells from HIV-infected patients for single-cell RNA sequencing and integration analysis. STAR Protoc. 2023;4(2):102222.
Xu H, Tan S, Zhao Y, Zhang L, Cao W, Li X, Tian J, Wang X, Li X, Wang F, et al. Lin PU.1 GATA-1 defines haematopoietic stem cells with long-term multilineage reconstitution activity. Cell Prolif. 2023:e13490.
Zhao Y, Weng Z, Zhou X, Xu Z, Cao B, Wang B, Li J. Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2. J Transl Med. 2023;21(1):219.
Zhao Y, Ding Y, He L, Zhou Q, Chen X, Li Y, Alfonsi MVittoria, Wu Z, Sun H, Wang H. Multiscale 3D genome reorganization during skeletal muscle stem cell lineage progression and aging. Sci Adv. 2023;9(7):eabo1360.
Li W, Wang X, Dong Y, Huo Q, Yue T, Wu X, Lu L, Zhang J, Zhao Y, Dong H, et al. Nicotinamide riboside intervention alleviates hematopoietic system injury of ionizing radiation-induced premature aging mice. Aging Cell. 2023:e13976.
Oprescu SN, Baumann N, Chen X, Sun Q, Zhao Y, Yue F, Wang H, Kuang S. Sox11 is enriched in myogenic progenitors but dispensable for development and regeneration of the skeletal muscle. Skelet Muscle. 2023;13(1):15.
Liu W, Zhao Y, Liu Z, Zhang G, Wu H, Zheng X, Tang X, Chen ZG. Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK. Cell Oncol (Dordr). 2023.

Pages